ImmunoTargets and Therapy

译名:免疫靶点与治疗

ESCIJCR Q2中科院2区

3-5

2026

影响因子区间

平台估算

投稿周期

68%

2025

中国作者发文占比

1700 USD

费用说明

收费

期刊简介:ImmunoTargets and Therapy is an international journal that aims to present and publish basic and clinical research on the aspects of immunology in health and disease. ImmunoTargets and Therapy is primarily focused on the immunological basis of disease and explores the evidence behind new and existing immunotherapies in terms of improving outcomes and, importantly, will seek to define their usage in terms of ultimate uptake and acceptance by the patient and health care professional. Specific Topics covered in this journal include: Biology and pathophysiology of the immune system in health and disease Immunological basis and immunological markers of diseases Potential targets for immune based therapy including therapeutic and prophylactic vaccines Novel and improved targets for immunodiagnostics and immunomonitoring Treatment protocols to improve management of patient with immune-mediated diseases Impact of management programs and new therapeutic agents Protocols on patient perspectives such as quality of life, adherence, and satisfaction Studies based on in-vitro research need to be supported by comprehensive experimental validation of results. ImmunoTargets and Therapy will no longer consider meta-analyses or Mendelian Randomization studies

【译文】《ImmunoTargets and Therapy》是一本国际期刊,旨在展示和发表健康和疾病免疫学方面的基础和临床研究。免疫目标和治疗主要关注疾病的免疫学基础,并探索新的和现有的免疫疗法在改善结果方面背后的证据,重要的是,将寻求从患者和医疗保健专业人员的最终吸收和接受角度来定义其使用。本期刊涵盖的具体主题包括: 健康和疾病中免疫系统的生物学和病理生理学 疾病的免疫学基础和免疫学标记 免疫治疗的潜在目标,包括治疗性和预防性疫苗 免疫诊断和免疫监测的新颖和改进目标 改善免疫介导疾病患者管理的治疗方案 管理计划和新治疗药物的影响 患者观点的方案,例如生活质量、依从性和满意度 基于体外研究的研究需要得到全面实验的支持结果验证。免疫目标和治疗将不再考虑荟萃分析或孟德尔随机研究

出版社
Dove Medical Press
语言
English
学科
农林科学 / 医学
ISSN
2253-1556
eISSN
2253-1556
出版频率
年刊
创刊年份
2002
投稿网址
https://www.dovepress.com/immunotargets-and-therapy-journal
最近更新
2026-04-02 18:16:40
ImmunoTargets and Therapy

指标当前值近三年趋势
JCR分区Q2
暂无
中科院分区2区
暂无
影响因子区间3-5
暂无